Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Why social supermarkets are gaining attention in the fight against food insecurity

22

Apr 2026

Why social supermarkets are gaining attention in the fight against food insecurity

This scoping review found that social supermarkets can offer a more dignified, choice-based way to access lower-cost food while also helping divert some surplus food from waste. However, the evidence suggests they work best as a complement to existing food support, not as a solution to the underlying causes of food insecurity or overproduction across the food system.

Study links common herbicide to rising early-onset colorectal cancer risk

22

Apr 2026

Study links common herbicide to rising early-onset colorectal cancer risk

Researchers used DNA methylation-based “epigenetic fingerprints” as proxies for lifelong exposome-related patterns and found that early-onset colorectal cancer was associated with lower Mediterranean diet adherence, lower education, smoking-related signatures, and higher picloram-related exposure signals. They then supported the picloram association in nine independent cohorts and with 21 years of US county-level pesticide-use data, while noting that the findings show association rather than proof of causation.

Low-plastic diets cut plastic-linked chemicals in urine within 7 days, study finds

22

Apr 2026

Low-plastic diets cut plastic-linked chemicals in urine within 7 days, study finds

A Nature Medicine study found that healthy Australian adults were widely exposed to plastic-associated chemicals, with processed, packaged, and canned foods emerging as important modifiable contributors to urinary phthalate and bisphenol levels. In a 7-day pilot randomized trial, low-plastic food interventions reduced several urinary plastic-associated chemicals without lowering daily energy intake.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.